Crowded House have postponed their US tour due to an injury sustained by drummer Elroy Finn.
The North American leg of the bandâs Dreamers Are Waiting Tour was expected to kick off in Philadelphia next week, with additional shows planned for New York City, Washington DC and Los Angeles, among others.
However, Crowded House frontman Neil Finn revealed yesterday (August 25) that those stops would be delayed following a âpainfulâ injury to Elroyâs lower back.
âWe are advised that there may be some risk in the recovery process for him to play shows at this time,â Finnâs message read. âThe good health and future well-being of the band members has to be our priorityâ.
Crowded House are disappointed to announce that we must postpone our upcoming North American tour. Â Our drummer Elroy is…
Posted by Crowded House on Thursday, August 25, 2022
Finn went on to explain that Elroy is receiving treatment for the injury, and assured fans that the drummer âwill fully recover in a matter of weeks given rest and rehabilitationâ. Finn later cited Crowded Houseâs previous ‘Dreamers Are Waiting’ tour dates in Europe and the UK as evidence of the rock groupâs development âinto a formidable live band over the past yearâ, before promising an updated tour schedule âas soon as we canâ.
Crowded Houseâs North American run of shows was slated to finish with a performance at Vancouverâs Orpheum Theatre on October 3. The tourâs current final leg is scheduled in Australia throughout November. Those Australian dates â some of which will enlist support acts Angus & Julia Stone, Boy and Bear and The Waifs â were themselves rescheduled in May following Neil Finnâs COVID-19 diagnosis.
Crowded Houseâs previous Australian tour dates â their first in 12 years â took place in support of their 2021 album, âDreamers Are Waitingâ. Speaking of the bandâs seventh studio record in an interview with NME, Finn said the album has âthe celebratory feeling about having the band back togetherâ.
The post Crowded House postpone US tour following Elroy Finn injury appeared first on NME.